why Lexicon Pharmaceuticals Inc [LXRX] is a Good Choice for Investors After New Price Target of $2.95
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] traded at a low on N/A, posting a -2.88 loss after which it closed the day’ session at $0.69. The results of the trading session contributed to over 7345028 shares changing hands. Over the past one week, the price volatility